Munich, 12 February 2025 - Dr. Philip Groth will take over the position of Managing Director of Cherry Digital Health GmbH, a subsidiary of Cherry SE, on March 1, 2025.

On 1 March 2025, Dr. Groth, an experienced manager in the pharma and health tech space with a focus on leadership, business growth, governance and strategic transformation will take over responsibility for the digital health business at CHERRY. He succeeds Gerrit Schick, who is leaving the company at his own with effect of 17 March 2025.

Dr. Groth has a distinguished multinational track record in strategic and operational leadership, specializing in digital transformation within the medical and pharmaceutical sectors. He adeptly navigates a complex ecosystem of corporations, mid-sized enterprises, start-ups, and public authorities, including the national agency for digital medicine, gematik, as well as key decision-making bodies in this highly regulated market. His career highlights include leadership roles at CompuGroup Medical SE & Co. KGaA and Bayer AG. Most recently, as CEO of Cerascreen GmbH, Dr. Groth played a pivotal role in advancing the development and market readiness of innovative digital products.

In his role at CHERRY, Dr. Groth will be responsible for shaping the company's global strategic direction in digital health. His focus will be on advancing the software and cloud product roadmap, implementing scalable business models, and driving international expansion.

Focus on expanding the CHERRY eHealth card terminal platform

Building on CHERRY's leading market position in eHealth terminals and related digital service solutions, the Cherry SE Executive Board has tasked Dr. Groth with the following directives:

• Development of the digital eHealth strategy 2025+
• Designing a comprehensive cloud, software and hardware roadmap
• Expansion of the cloud service offering
• Market launch of new healthcare services
• Development and implementation of a partner-oriented go-to-market concept with a view to the growth potential of hospitals, doctors' surgeries and pharmacies through to other service providers such as physiotherapists and midwives.
• Expansion of the partner and collaboration network to optimize the sales approach

Under the leadership of Gerrit Schick, Cherry SE's digital healthcare business has experienced strong growth. In 2024 alone, the company achieved a sales increase of more than 30% compared to the previous year.

Statements from the management

Dr. Philip Groth:

"I am very excited about my new role at Cherry Digital Health and see tremendous potential in combining innovative hardware, software, and digital services for the healthcare sector. CHERRY has a strong market position and an established product portfolio, which we will continue to enhance and expand internationally. Together with the team, I am committed to driving digitalization in healthcare and creating sustainable solutions for a more connected and secure healthcare ecosystem."

Oliver Kaltner, CEO of Cherry SE:

"We are pleased to announce another top-tier appointment in 2025 with Dr. Philip Groth. As a highly respected and well-connected healthcare expert, he has been deeply committed to the much-needed digitalization of the medical sector across various companies and committees. A key priority will be shaping this business as a platform for collaboration among a diverse range of stakeholders.

In this context, we would like to express our sincere appreciation for the outstanding development of Cherry eHealth under the leadership of Gerrit Schick in recent years. He is handing over a business with a strong market position, built on a steadfast commitment to meeting the technical and digital needs of all participants in the healthcare sector, creating a solid foundation for continued growth.

We wish Dr. Philip Groth great success in his new role at CHERRY and extend our best wishes to Gerrit Schick for his future professional and personal endeavors."

About Cherry

Cherry SE [ISIN: DE000A3CRRN9] is a global manufacturer of high-end switches for mechanical keyboards and computer input devices such as keyboards, mice, and headsets for applications in the fields of Gaming & E-Sports, Office & Hybrid Workplaces, Industry, and Healthcare. Since its founding in 1953, Cherry has been known for innovative, high-quality products specifically designed to meet diverse customer needs.

Cherry’s operational headquarters is in Auerbach in der Oberpfalz (Bavaria) and it employs staff in production facilities in Auerbach, Zhuhai (China), and Vienna (Austria), as well as several sales offices in Auerbach (Germany), Munich (Germany), Landskrona (Sweden), Paris (France), Kenosha (USA), Chicago (USA), Hongkong (China), Taipei (China) and Shanghai (China).

For more information, visit:/en/

Contact

Cherry SE

Nicole Schillinger

Investor Relations

P: Rosental 7, c/o Mindspace, 80331 Munich

T: +49 (0) 9643 2061 848

E: